MAXZIDE-25 (HYDROCHLOROTHIAZIDE; TRIAMTERENE) — FDA Approval NDA019129 (AUROBINDO PHARMA USA)
MAXZIDE-25 (HYDROCHLOROTHIAZIDE; TRIAMTERENE) — FDA Approval NDA019129 (AUROBINDO PHARMA USA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: MAXZIDE-25; Active ingredients: HYDROCHLOROTHIAZIDE; TRIAMTERENE; Application number: NDA019129.
| Brand name | MAXZIDE-25 |
|---|---|
| Active ingredients | HYDROCHLOROTHIAZIDE; TRIAMTERENE |
| Application number | NDA019129 |
| Sponsor | AUROBINDO PHARMA USA |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 19841022 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →